Wednesday, December 19, 2012

Cancer Vaccine Saves Lives, But FDA Doesn't Get The Message


Many lives have been saved by a personalized vaccine for non-Hodgkin's lymphoma cancer called BioVax ID. But inexcusably, BioVax ID, which has been around since 1994, remains unapproved by the Food and Drug Administration (FDA) and is unavailable to many patients.

The FDA says it denied a request for accelerated approval for this vaccine from the company, Biovest, because the vaccine does not fill an unmet need. But patients and patient advocates I've spoken to across the nation strongly disagree.

Betsy de Parry, a respected author, patient advocate, and non-Hodgkin's lymphoma survivor, recently wrote about the vaccine, pointing out that data from three clinical trials spanning 18 years shows the duration of response to this vaccine increased, on average, by more than a year, although some patients have remained disease free for many years. 

And importantly, she wrote, "not a single patient has experienced a serious, adverse vaccine-related event, which makes the vaccine less toxic than existing treatments."

Sounds to me like a legitimate reason for moving this product forward, and quickly. But the Feds turned down the company's request to apply for approval under the agency's Accelerated Approval Program, which allows for earlier approval of drugs that treat serious disease and fill an unmet need. The FDA told the company to conduct another clinical trial and then come back with another request for approval, which will take years. 

But now patient advocates and patients are speaking out. A petition urging the FDA to accelerate approval of BioVax ID is getting a lot of national attention. I urge readers of this blog to please sign the petition here. It will save lives.

There are many promising new cancer treatments that are delayed, often needlessly, by the FDA. Out of more than 900 new cancer drugs in the pipeline, the FDA did not approve a single new drug for lymphoma this year. The Feds are dropping the ball here and not serving the needs of cancer patients. 

Yes, part of the FDA's mandate is to keep us safe. But the other part of the FDA's charter is getting new, safe and effective drugs to the market. That means you and me. In its fears over the first, the FDA is lagging on the second part of its mission. 

The BioVax ID vaccine has 18 years of trial data and no serious vaccine-related adverse events. Considering its safety, there is absolutely no justifiable reason why the FDA can't grant this vaccine an application for accelerated approval so the company can go out and raise the millions of dollars it needs to do the phase III trial and get this approved. 

It's the right thing to do. And you can help get this moving. Let your voice be heard. Please join me in signing this petition for the benefit of cancer patients nationwide. And stay tuned to this blog for news about this vaccine and other very promising cancer treatments.

13 comments:

  1. Great post, Jamie. All of us who are potential candidates to get cancer, not just cancer survivors, have to be outraged by this arrogant attitude on the part of the FDA. Since this administration thinks its above the normal rules in a free society, everyone needs to demand their congressional representatives earn their pay and take action. You've done your part, now its up to the rest of us.

    ReplyDelete
  2. Every body wants to be cancer free. I hope FDA will give a chance to consider this. There is a high ratio of cancer mortality, we need to do something about it. Management for cancer like radiotherapy and chemo are expensive. Studies for alternative medicine cancer treatment must be pushed through.

    ReplyDelete
  3. Please allow cancer patients a choice, we are willing to try anything!
    Thanks

    ReplyDelete
  4. I'm a HL survivor and I have been following this story. I have a few question. Are members of congress going to step up to the plate & do what's right? Is this just being fought and refused by the FDA? I've signed the petition and asking ppl to sign. Thx!

    ReplyDelete
  5. Liver cancer is defined as a condition of out of controlled growth of hepatocellular cells in the liver. Since the organ is a soft tissue with less nerve, most liver cancer patient are diagnosed in the later stage of the cancer. According to the statistic, liver cancer remains the fifth most common malignancy in men and the eighth in women worldwide.
    Cancer cure India
    Cost of cancer treatment in India
    Prostate cancer treatment in India
    Medical treatment in India

    ReplyDelete
  6. I have been in remission for over 3 years from NHL after receiving an experimental Vaccine through a clinical trial (I haven't had chemo or any other treatment) developed at Stanford University (Dr. Ron Levy). I had minimal to no side effects. I am a mom to young children and this vaccine has given me my life back. I know others who I talk to and keep in touch with and who are alive decades later due to receiving lymphoma vaccines. More research is needed. There is a subset of patients that benefits from these vaccines (Dr. Schuster is researching this). Also read about Mary Disis M.D. and her breast cancer vaccine.
    I am a big believer in vaccines. Great article Jamie. Thank you for fighting for us!!! You are an inspiration!!

    ReplyDelete
    Replies
    1. Thanks so much for this reply, and congrats on your remission. Indeed, despite what TIME magazine claims, cancer vaccines can and DO work!!!

      Delete
  7. Thank you for your very informative post! Feel free to visit our cancer center website to explore more alternative treatments to cancer.

    ReplyDelete
  8. what? they don't care about vaccine?
    the cancer vaccine can save many life, i'm dissapointed to hear that, very.
    i'm agree with your statment,
    regards from Agen Bola

    ReplyDelete